- Grants
- $3.2M
- 4 awards
- Sector median: 1
- Raised
- $2.5M
- 11 Form D · Feb 2026
- 7 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 10
- 2 granted · 8 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20112013201520172019202120232025
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $400,000 | |
| Private capital raised | Form D · SEC | $142,000 | |
| Private capital raised | Form D · SEC | $120,000 | |
| Federal grant | Department of Defense · Phase I · Infectious Disease Diagnostics and Differentiation of Viral vs. Bacterial Infections for Point of Care Applications | $150,524 | |
| Private capital raised | Form D · SEC | $110,741 | |
| Private capital raised | Form D · SEC | $55,000 | |
| Federal grant | Department of Defense · Phase II · Infectious Disease Diagnostics and Differentiation of Viral vs. Bacterial Infections for Point ofCare Applications | $994,238 | |
| Private capital raised | Form D · SEC | $150,000 | |
| Private capital raised | Form D · SEC | $38,365 | |
| Private capital raised | Form D · SEC | $124,997 | |
| Federal grant | Department of Defense · Phase II · Infectious Disease Diagnostics and Differentiation of Viral vs. Bacterial Infections for Point of Care Applications | $999,752 | |
| Private capital raised | Form D · SEC | $1,200,000 | |
| Federal grant | Department of Defense · Phase II · GeneCapture's Fieldable Diagnostic Platform for Rapid ID and AST of Wound Pathogens | $1,099,957 | |
| Private capital raised | Form D · SEC | $500,000 | |
| Private capital raised | Form D · SEC | $50,000 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1485 | OBSIDIO, INC. | — | — |
| 1486 | Nyra Medical, Inc. | — | $12M |
| 1487 | Vasc-Alert LLC | — | $163K |
| 1488 | GENECAPTURE, INC. | — | $2.5M |
| 1489 | Decision Sciences Medical Co LLC | — | $12M |
| 1490 | ASC San Rafael LLC | — | $28M |
| 1491 | Atlanta Catheter Therapies, Inc. | — | $2.4M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Michael ChambersDirector
- Krishnan ChitturDirector · Executive Officer
- Tim NewellDirector
- Peggy SammonDirector · Executive Officer
Patents
- Integrated Cartridge For Sample Homogenization And Nucleic Acid Fragmentationapplication
- Compositions, Methods And Devices Comprising Stem-loop Captor Moleculesapplication
- Integrated Cartridge For Sample Homogenization And Nucleic Acid Fragmentationgranted
- Compositions, Methods And Devices Comprising Stem-loop Captor Moleculesgranted
- Methods And Systems For Determining Target Sensitivity To A Therapeutic Formulaapplication
- Design And Use Of Structured Stem-loop Captors For Target Nucleotide Detectionapplication
- Methods And Systems For Determining Target Sensitivity To A Therapeutic Formulaapplication
- Cartridge Concept And Method For Integrated Homogenization And Fragmentation Of Rna Using Ultrsonic Energyapplication
- Methods And Systems For Determining Target Sensitivity To A Therapeutic Formulaapplication
- Compositions, Methods And Devices Comprising Stem-loop Captor Moleculesapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.